Navigating Hormone Decline with Personalized Medicine

Navigating Hormone Decline: An Integrative Clinician’s Guide to Hormone Replacement Therapy

Abstract

In this educational post, I will guide you through the complex world of hormone decline and the various methods of Hormone Replacement Therapy (HRT). Drawing on my clinical experience and the latest evidence-based research, we will explore the profound impact of declining hormone levels—such as estrogen, progesterone, and testosterone—on all individuals. I will detail the common symptoms, from mood disturbances and sleep issues to metabolic changes and chronic pain, and explain the physiological reasons behind them. We will then thoroughly examine the various HRT modalities available, including injections, creams, pellets, and oral/sublingual options, carefully considering their advantages and disadvantages. We will emphasize personalized medicine, using tools such as the Menopause Rating Scale, comprehensive lab tests, advanced dosing strategies, and patient history. Throughout this discussion, I will explain how integrative chiropractic care complements these treatments by addressing the body’s structural and neurological health, creating a holistic framework to optimize patient well-being and achieve true vitality.

The Overwhelming Feeling of Hormonal Imbalance

In my practice, I often encounter patients who feel like they are losing control of their bodies and minds. A picture I sometimes show them, one depicting a person overwhelmed and frazzled, resonates deeply. They describe their mood not just as “out of control” but as a debilitating mix of depression, anxiety, and irritability. They can’t sleep, they can’t focus, and they feel a profound sense of being disconnected from themselves. I’ve had patients tell me, “I feel like I’m losing my mind,” or, “I want to kill everybody, and I don’t even have a good reason why.” These feelings are not a personal failing; they are often the direct result of a significant hormonal shift.

The primary complaints I hear are consistent and telling:

• Inability to Sleep: Many struggle with insomnia, particularly waking up between 2 and 4 a.m. This is a hallmark sign of an anxious mind, often fueled by hormonal dysregulation.
• Persistent Fatigue: A common report is “hitting a wall” in the mid-afternoon. While many dismiss this as a normal part of the day, it’s often a sign of an underlying imbalance that a cup of coffee can’t truly fix.
• Loss of Libido and Vitality: Men frequently tell me, “My get-up-and-go got up and went.” They lose the desire to engage in hobbies they once loved, like fishing or riding motorcycles. For men, this often manifests as low libido, erectile dysfunction, and a loss of morning erections—a classic symptom of testosterone insufficiency.
• Metabolic Changes: Patients notice they can’t lose weight, no matter how hard they try. They may also experience night sweats, which can be a symptom of both testosterone and estrogen deficiency.
• Chronic Pain: Conditions like fibromyalgia and other chronic pain syndromes are frequently linked to hormone decline. The intricate interplay between hormones and our inflammatory and pain-sensing pathways means that a deficiency can amplify pain perception throughout the body.

These symptoms are not isolated issues; they are interconnected signs of the body’s hormonal orchestra falling out of tune.

Essential Tools for Assessment: The Menopause Rating Scale (MRS)

To truly understand a patient’s journey, we must begin with a solid baseline. One of the most invaluable tools I use in my clinic is the Menopause Rating Scale (MRS).

• Validated and Reliable: The MRS is a scientifically validated tool, translated into over 90 languages, and has demonstrated strong validity and reliability. It’s an open-access resource, meaning it’s readily available for clinical use.
• Tracks Subjective Symptoms: Its primary purpose is to capture a patient’s subjective report of symptoms before initiating any pharmacotherapy and then again at follow-up visits. This allows us to objectively measure the efficacy of our treatment plan.
• Empowers Patients: By seeing their scores improve, patients can tangibly recognize how much better they feel. It validates their experience and reinforces the positive changes happening in their bodies.

Many forward-thinking practices, including my own, incorporate the MRS into all new patient paperwork. A patient might come in for what they believe is a simple issue, like dyspepsia, but their MRS score reveals moderate to severe symptoms of hormone deficiency. This becomes a powerful conversation starter. I can then say, “I see from your questionnaire that you’re experiencing a lot of symptoms consistent with hormone imbalance. I think it would be wise to run some labs to investigate this further.” This proactive screening is a cornerstone of our integrative approach.

Comprehensive Lab Work: Looking Beyond the Basics

To create a truly personalized treatment plan, we need a comprehensive view of a patient’s physiology. We always get labs done before the initial consultation. A common question I get is whether a patient already on hormone replacement therapy (HRT) needs to stop before their blood draw. The answer is no; our dosing models are sophisticated enough to account for existing treatments. An integrative approach demands a deeper dive than a basic panel.

Recommended Labs for Females:

• Hormones: Total and Free Testosterone, Estradiol (E2), Progesterone, DHEA-Sulfate (DHEA-S), Follicle-Stimulating Hormone (FSH), and Luteinizing Hormone (LH).
• Thyroid Panel: A full thyroid workup is crucial, as thyroid function is intimately linked to sex hormone balance.
• General Health Markers: Complete Blood Count (CBC) and Comprehensive Metabolic Panel (CMP).
• Integrative Markers: Vitamin D, Hemoglobin A1c & Fasting Insulin, C-Reactive Protein (CRP), and Ferritin.

Recommended Labs for Males:

• The panel is very similar, focusing on total and free testosterone, DHEA-S, thyroid, and the same general and integrative health markers.
• Prostate-Specific Antigen (PSA): This is an essential baseline and follow-up marker for men.
• Estradiol: I don’t routinely test estrogen in men unless there are specific symptoms like gynecomastia (enlargement of male breast tissue). Elevated estrogen in men is often a result of aromatization from testosterone, and if the patient is asymptomatic, aggressive intervention may not be warranted.

The Art of Medicine: Layering Therapies and Dosing Strategies

In my years of practice, I’ve observed that women’s bodies are incredibly responsive systems. This heightened awareness is crucial when we approach hormone therapy. Imagine a female patient whose lab work shows suboptimal DHEA and thyroid levels, alongside symptoms of estrogen, progesterone, and testosterone imbalance. The temptation to address everything at once can be counterproductive. If a system is already out of balance, introducing multiple variables simultaneously makes it impossible to identify the culprit if an adverse reaction occurs.

This is where the “art of medicine” and a layered therapy strategy come into play. We introduce treatments one by one, or in carefully considered combinations, allowing the body to adapt and providing us with clear feedback. For instance, with a patient new to hormone therapy, I might start with testosterone alone for a few months. The rationale is to “wake up” the androgen receptors and allow for a small amount of natural conversion to estrogen. This gentle introduction nudges dormant estrogen receptors before I introduce a low dose of estradiol. This careful, stepwise approach is a clinical art form, guided by experience, and critical to success.

The guiding principle must be: “start low, go slow,” especially for patients who are further out from menopause. Consider two women with identical lab profiles—low testosterone, low estrogen, and elevated FSH. One is 52 and a few years post-menopause. The other is 72. If I give them both the same starting dose, the 52-year-old will likely feel amazing. The 72-year-old, however, may feel awful—nauseous, with breast tenderness and spotting. Her hormone receptors have been dormant for over 20 years. Blasting them with hormones is a shock to the system. We must gently reawaken the system, baby-stepping the dose up over time.

Decoding the Hormones: FSH, Estrogen, and Testosterone

FSH: The Brain’s Cry for Estrogen

In postmenopausal women, Follicle-Stimulating Hormone (FSH) is one of our most telling indicators. As the ovaries cease producing estrogen, a feedback loop to the brain is disrupted. The brain senses low estrogen and tries to stimulate the ovaries by releasing more and more FSH. It doesn’t know the ovaries have “retired.” This is why we see a very high FSH in symptomatic postmenopausal women. Our therapeutic goal is to lower this FSH by providing the body with the estrogen it’s missing, thereby quieting the brain’s frantic signals. My initial goal with HRT is to cut the baseline FSH in half. Over time, the “sweet spot” where patients report feeling their absolute best is often when their FSH is around 10.

The Perimenopause Lesson: Treat the Patient, Not the Labs

It’s crucial not to be misled by a single estrogen level, especially in perimenopausal women whose hormones fluctuate wildly. The most important question is: “Are you still having menstrual cycles?” I learned this lesson the hard way early in my career. A friend came to me, miserable with hot flashes. Her labs showed high FSH and an estradiol of 98. Thinking I would be her hero, I prescribed a robust dose of estrogen. Two weeks later, she called me, furious, with extreme breast tenderness and heavy bleeding. The critical question I had failed to ask was about her menstrual cycle. She was still perimenopausal. Until a woman has gone 12 consecutive months without a period, she should be treated as perimenopausal. That experience taught me to always treat the patient and their clinical history, not just the lab numbers.

Testosterone in Women: Beyond “Normal” Ranges

One of the biggest misunderstandings surrounds testosterone in women. There are currently no established “normal” ranges for testosterone in women that correlate with symptoms. We now recognize Female Androgen Insufficiency Syndrome, characterized by reduced libido, fatigue, and loss of well-being. As multiple studies summarized in the Endocrine Society’s clinical practice guideline on Androgen Therapy in Women: A Reappraisal conclude, since we cannot reliably diagnose this with a blood test, we should treat based on symptoms. Dr. Rebecca Glaser, a brilliant researcher, has published excellent papers explaining why women often require what might be considered supraphysiologic levels of testosterone to achieve symptom relief (Glaser & Dimitrakakis, 2013). Her work highlights that what happens at the cellular receptor level is not measurable by our current lab tests. This leads to a vital conclusion: treat the patient, not the lab report.

Understanding the Methods of Hormone Replacement

When we decide HRT is the right path, it’s crucial to understand the different delivery methods.

Testosterone and Estrogen Pellets

Pellets deliver a continuous, steady-state form of hormone replacement, preventing the “roller coaster” effect of peaks and valleys. Made from compressed hormones, they are inserted into fatty tissue and slowly dissolve over three to five months. The main downside is that once pellets are in, they can’t be easily taken out. It’s critical to understand that not all pellets are created equal; their manufacturing process affects their dissolution rate.

Creams and Gels

Topical creams can have unpredictable absorption, and skin receptors can become desensitized. We have found that scrotal and labial application yields the best results due to the thin, highly vascular skin. Commercially available products like Androgel are often in an alcohol base, which burns on scrotal skin, necessitating a compounded cream in a more suitable base. Monitoring hormone levels with creams is difficult, as lab results can be falsely elevated and do not reflect systemic levels.

Injections

Injections are a common and effective method, particularly for testosterone in men. Shots are typically administered intramuscularly (IM) weekly or biweekly. A standard starting dose for a 50-year-old male is around 200 mg of testosterone cypionate per week, but this is highly variable. I generally do not prefer testosterone shots for women, as I’ve seen them lead to more pronounced masculinizing side effects.

Oral and Sublingual Therapies

• Oral Testosterone: I do not recommend oral testosterone. When swallowed, it undergoes a “first-pass effect” through the liver, where it is heavily metabolized into metabolites linked to higher estrogen levels and associated risks.
• Sublingual RDTs (Rapidly Dissolving Tablets) are a much better option. Placed under the tongue, the tablet is absorbed directly into the bloodstream, bypassing the liver. In my practice, we’ve seen great success with sublingual testosterone RDTs for women, with a typical effective dose between 4-10 mg daily.

The Crucial Role of Progesterone

Progesterone is the calming, balancing hormone. For a postmenopausal woman on estrogen therapy who still has her uterus, the absolute standard of care is to also prescribe progesterone to protect the uterine lining. The standard dose is 200 mg of micronized oral progesterone at night. In perimenopause, a steep decline in progesterone while estrogen is still high drives mood swings, anxiety, and insomnia. Nightly progesterone can dramatically improve quality of life. If oral progesterone causes excessive drowsiness, we can switch to a sublingual formulation to avoid first-pass hepatic metabolism, which is responsible for this side effect.

Advanced Protocols for Complex Cases

Hormone optimization often involves navigating complex comorbidities and medication interactions.

• Chronic Pain and ADHD Medications: I’ve observed that patients on chronic opioid therapy or certain ADHD medications often require higher starting doses of testosterone. These medications can increase levels of Sex Hormone Binding Globulin (SHBG), a protein that binds testosterone, rendering it inactive. To achieve a therapeutic effect, we must provide enough testosterone to overcome this increased binding capacity.
• The SSRI Conundrum: Selective Serotonin Reuptake Inhibitors (SSRIs) are frequently given for symptoms like anxiety and depression, which are often manifestations of hormonal imbalance. Their most common side effects are weight gain and low libido—the very issues I am often trying to fix. When appropriate, I create a plan to wean them off the SSRI as we begin hormone therapy. This process must be slow, methodical, and documented with signed, written instructions to ensure patient safety and prevent serotonin withdrawal syndrome.

Integrative Chiropractic Care: The Foundational Element

As a practitioner with deep roots in chiropractic care, I see the body as an integrated whole. Hormone therapy is a powerful tool, but it works best when the body’s foundational systems are functioning optimally. This is where integrative chiropractic care becomes essential.

The nervous system is the body’s master controller, including the endocrine (hormone) system. Spinal misalignments, or subluxations, can interfere with the nerve signals traveling between the brain and the glands that produce hormones.

By performing precise chiropractic adjustments, we can:

• Restore Proper Nerve Function: Correcting subluxations helps ensure communication pathways between the brain and endocrine glands are clear. This can help the body regulate its own hormone production more efficiently and respond better to HRT.
• Reduce Physical Stress: Chronic pain from poor posture or spinal issues places a huge demand on the adrenal glands, leading to adrenal fatigue. This disrupts the cortisol rhythm, which in turn affects sex hormone production. Chiropractic care directly addresses this physical stress.
• Improve Overall Well-being: Patients receiving chiropractic care often report better sleep, reduced pain, and improved mood—symptoms we aim to treat with HRT. By combining these approaches, we create a synergistic effect. The structural integrity provided by chiropractic adjustments creates a healthier, more resilient vessel for the biochemical balance we achieve with hormone therapy.

By combining evidence-based hormone replacement therapy with foundational chiropractic care, we can guide our patients on a comprehensive journey to wellness, addressing the root causes of their symptoms and restoring them to vibrant health.

References

American Association of Clinical Endocrinologists. (2017). American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Clinical Practice for the Diagnosis and Treatment of Menopause. Endocrine Practice, 23(Suppl 3), 1-82. https://www.endocrinepractice.org/article/S1530-891X(20)42735-8/fulltext

Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018). Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1715–1744.

Glaser, R., & Dimitrakakis, C. (2013). Testosterone therapy in women: myths and misconceptions. Maturitas, 74(3), 230-234.

Kucharz, E. J., & Rell-Bakalarska, M. (2020). The role of DHEA in the pathogenesis and treatment of fibromyalgia. Journal of Clinical Medicine, 9(4), 934.

Rouzier, N. (2021). How to Achieve Healthy Aging: The Ultimate Guide to Natural Hormone Replacement. Worldlink Medical Publishing.

Schneider, H. P., Heinemann, L. A., Rosemeier, P., Potthoff, P., & Behre, H. M. (2003). The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints. Climacteric, 6(3), 250-258.

Stachenfeld, N. S. (2014). Hormonal changes during menopause and the impact on fluid regulation. Reproductive Sciences, 21(5), 555-561.

The North American Menopause Society. (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause, 29(7), 767-794.

Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., & Santoro, N. (2014). Androgen therapy in women: A reappraisal: An endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 99(10), 3489–3510.